GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹16 Cr | ₹22 Cr | ₹13 Cr | ₹75 Cr | ₹12 Cr |
What is the latest Contingent Liabilities ratio of GLAND PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹16 Cr |
Mar2023 | ₹22 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹75 Cr |
Mar2020 | ₹12 Cr |
How is Contingent Liabilities of GLAND PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹16 Cr | -29.41 | |
Mar2023 | ₹22 Cr | 72.94 | |
Mar2022 | ₹13 Cr | -82.91 | |
Mar2021 | ₹75 Cr | 531.25 | |
Mar2020 | ₹12 Cr | - |
Compare Contingent Liabilities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹30,637.1 Cr | -0.9% | 11.5% | -9.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | -0.9% |
11.5% |
-9.1% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses